SOURCE: Industrial Info Resources

Industrial Info Resources

May 13, 2011 06:10 ET

Big Pharma Merger & Acquisition Binge Continues as Top Three Deals in 2011 Soar to $65 Billion, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwire - May 13, 2011) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- It has become obvious that the Pharmaceutical-Biotech Industry considers mergers and acquisitions a key factor to growth, and there appears no end in sight to this feeding frenzy. A number of pundits weighed in earlier this year that M&A activity would soon taper off. On the contrary, the past few weeks have seen scores of deals and plans announced across the entire spectrum of the industry.

Life science giant Johnson& Johnson (NYSE:JNJ) (New Brunswick, New Jersey) will knock it out of the park in terms of dollar amount, when it closes on its $21.3 billion deal to buy medical device manufacturer Synthes Incorporated (Solothurn, Switzerland).

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at, or browse other breaking industrial news stories at

Industrial Info Resources (IIR), with world headquarters in Sugar Land, Texas, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. IIR's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. For more information send inquiries to or visit us at

Follow us on: Facebook - Twitter - LinkedIn

Contact Information

  • Contact:
    Joe Govreau